MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ajhp/zxag136

Медицинская библиотека · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2026

Central nervous system-active medication polypharmacy among rural and urban veterans with fibromyalgia, migraine, or irritable bowel syndrome.

Hadlandsmyth Katherine, Lund Brian C

СтатьяПеревод в очереди

Аннотация

PURPOSE: This study examined whether rural veterans with multisymptom chronic pain presentations, including those diagnosed with fibromyalgia, migraine, and/or irritable bowel syndrome (IBS), were at heightened risk for polypharmacy with central nervous system (CNS)-active medications, a potentially risky prescribing practice.

METHODS

Administrative data were used to identify veterans receiving care for fibromyalgia, migraine, or IBS during 2022. Negative binomial regression models, conducted separately for fibromyalgia, migraine, and IBS, examined the impact of rural residence and rural site of care on number of concurrent CNS medications. Models were then adjusted for demographics and medical and psychiatric comorbidities.

RESULTS

A total of 250,533 veterans were treated for fibromyalgia (n = 30,462), migraine (n = 188,640), and/or IBS (n = 49,169) in the Veterans Health Administration in 2022. Rates of polypharmacy were 16.2% for those with fibromyalgia, 13.5% for those with migraine, and 8.2% for those with IBS. In fibromyalgia, rural veterans' mean number of concurrent CNS-active medications was 2.59 (SD, 1.92), compared to 2.63 (SD, 1.90) for urban veterans; in migraine, the mean (SD) number of concurrent medications was 2.43 (1.87) in rural veterans, compared to 2.40 (1.83) in urban veterans; and in IBS, the mean (SD) number of concurrent medications was 1.75 (1.75) in rural veterans, compared to 1.79 (1.75) in urban veterans. In adjusted analyses, minimal differences were found between rural and urban-dwelling veterans in the risk of an increased number of concurrent CNS medications (adjusted incident rate ratios [aIRRs] ranged from 1.01 to 1.03) and between those receiving primary care from rural clinics versus medical centers (aIRRs ranged from 0.95 to 0.97).

CONCLUSION

These findings do not support the hypothesis that rural veterans are at increased risk for CNS polypharmacy.

Для цитирования: Hadlandsmyth Katherine, Lund Brian C. Central nervous system-active medication polypharmacy among rural and urban veterans with fibromyalgia, migraine, or irritable bowel syndrome.. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2026. DOI: 10.1093/ajhp/zxag136.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.